Tdap combined vaccine (absorbed, two-component) (Changchun BCHT Biotechnology)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameTdap combined vaccine (absorbed, two-component) (Changchun BCHT Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Toxoid vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTetanusDiphtheriaWhooping Cough
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChangchun Bcht Biotechnology Co
China Registration ClassN/A

Develop Information

Active CompaniesChangchun Bcht Biotechnology Co
Inactive CompaniesN/A
Active IndicationsTetanusDiphtheriaWhooping Cough
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A